Dr Lorin Gresser is the CEO of Dem Dx, an award-winning AI healthcare company based in London. The company’s CE certified clinical diagnostic platform, developed in consultation with over 200 medical experts, enables frontline practitioners to diagnose, identify necessary tests and present recommendations for further care before the patient sees a doctor.
The Dem Dx platform is 22% more accurate than Harvard-trained junior doctors, delivers 85% accuracy at first diagnosis, and reduces time to diagnose by 40%.
Lorin studied Natural Sciences at Cambridge University and went on to do an MBA at Harvard Business School before returning to the UK to study medicine at Kings.
DemDx was established in 2015.
Subscribe
A Podcast Company -